Structured evidence table for Green Tea Extract Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Green Tea Extract Blood Pressure Randomized Trial | Blood glucose level, glycated hemoglobin level, body weight, and fat mass decreased with green tea intervention, while muscle mass increased across all groups (all p Trial Registration: University Hospital Medical Information Network (UMIN): UMIN000058708. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Green Tea Extract Blood Pressure Randomized Trial | Catechins in green tea have been reported to enhance glucose tolerance and lipid metabolism. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Green Tea Extract Blood Pressure Randomized Trial | However, the influence of chronic intake timing on these outcomes in older adults has not been fully elucidated. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Green Tea Extract Blood Pressure Randomized Trial | Polyphenols strengthen the intestinal barrier and reduce endotoxemia; cocoa bean shell extracts protected against oxysterol‐induced intestinal damage and improved gut microbiota composition in preclinical models (Alia et al. ). | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
| Green Tea Extract Blood Pressure Randomized Trial | While many epidemiological studies correlate polyphenol‐rich diets (e.g., Mediterranean diet) with reduced NCCD risk, causality is uncertain due to confounding and measurement error. | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
| Green Tea Extract Blood Pressure Randomized Trial | Controlled trials provide more robust evidence but vary widely in doses, formulations, populations and endpoints. | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
| Green Tea Extract Blood Pressure Randomized Trial | AMP BBB CNS COMT COSMOS CRP (hs‐CRP) CSF EGCG ENB‐2 (ENB) ENS EVOO FMD GAD‐7 (GAD) GM‐CSF (GM) HDL HOMA‐IR (HOMA) IBS IL IR LDL LPS MCI MMSE NADPH NCCD (NCCDs) PHGG PHQ‐9 (PHQ) PSQI PWV RBANS RCT SCFA SD TNF (TNF‐α) 2024 Non‐communicable chronic diseases account for the majority of morbidity and mortality worldwide. | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
Source documents